K G Samsom
K G Samsom
Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by K G Samsom in
Google Scholar
PubMed
Search for other papers by K G Samsom in
Google Scholar
PubMed
L M van Veenendaal
L M van Veenendaal
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by L M van Veenendaal in
Google Scholar
PubMed
Search for other papers by L M van Veenendaal in
Google Scholar
PubMed
G D Valk
G D Valk
Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands
Search for other papers by G D Valk in
Google Scholar
PubMed
Search for other papers by G D Valk in
Google Scholar
PubMed
M R Vriens
M R Vriens
Department of Surgical Oncology and Endocrine Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands
Search for other papers by M R Vriens in
Google Scholar
PubMed
Search for other papers by M R Vriens in
Google Scholar
PubMed
M E T Tesselaar
M E T Tesselaar
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by M E T Tesselaar in
Google Scholar
PubMed
Search for other papers by M E T Tesselaar in
Google Scholar
PubMed
J G van den Berg
J G van den Berg
Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by J G van den Berg in
Google Scholar
PubMed
Search for other papers by J G van den Berg in
Google Scholar
PubMed
SI-NETs, liver metastases RNA sequencing, Whole transcriptome microarrays, qPCR Serial differential expression was validated in 7/10 genes, with several interacting members of the AKT , MYC , or MAPK3 pathways. Liver metastases had
